Conducting national burden of disease studies and knowledge translation in eight small European states: challenges and opportunities.
Burden of disease
Knowledge translation
Research
Small countries
Journal
Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481
Informations de publication
Date de publication:
21 Oct 2022
21 Oct 2022
Historique:
received:
11
05
2022
accepted:
30
09
2022
entrez:
22
10
2022
pubmed:
23
10
2022
medline:
26
10
2022
Statut:
epublish
Résumé
Several countries across Europe are engaging in burden of disease (BoD) studies. This article aims to understand the experiences of eight small European states in relation to their research opportunities and challenges in conducting national BoD studies and in knowledge translation of research outputs to policy-making. Countries participating in the study were those outlined by the WHO/Europe Small Countries Initiative and members of the Cooperation in Science and Technology (COST) Action CA18218 European Burden of Disease Network. A set of key questions targeting the research landscape were distributed to these members. WHO's framework approach for research development capacities was applied to gain a comprehensive understanding of shortages in relation to national BoD studies in order to help strengthen health research capacities in the small states of Europe. Most small states lack the resources and expertise to conduct BoD studies, but nationally representative data are relatively accessible. Public health officials and researchers tend to have a close-knit relationship with the governing body and policy-makers. The major challenge faced by small states is in knowledge generation and transfer rather than knowledge translation. Nevertheless, some policy-makers fail to make adequate use of knowledge translation. Small states, if equipped with adequate resources, may have the capacity to conduct national BoD studies. This work can serve as a model for identifying current gaps and opportunities in each of the eight small European countries, as well as a guide for translating country BoD study results into health policy.
Sections du résumé
BACKGROUND
BACKGROUND
Several countries across Europe are engaging in burden of disease (BoD) studies. This article aims to understand the experiences of eight small European states in relation to their research opportunities and challenges in conducting national BoD studies and in knowledge translation of research outputs to policy-making.
METHODS
METHODS
Countries participating in the study were those outlined by the WHO/Europe Small Countries Initiative and members of the Cooperation in Science and Technology (COST) Action CA18218 European Burden of Disease Network. A set of key questions targeting the research landscape were distributed to these members. WHO's framework approach for research development capacities was applied to gain a comprehensive understanding of shortages in relation to national BoD studies in order to help strengthen health research capacities in the small states of Europe.
RESULTS
RESULTS
Most small states lack the resources and expertise to conduct BoD studies, but nationally representative data are relatively accessible. Public health officials and researchers tend to have a close-knit relationship with the governing body and policy-makers. The major challenge faced by small states is in knowledge generation and transfer rather than knowledge translation. Nevertheless, some policy-makers fail to make adequate use of knowledge translation.
CONCLUSIONS
CONCLUSIONS
Small states, if equipped with adequate resources, may have the capacity to conduct national BoD studies. This work can serve as a model for identifying current gaps and opportunities in each of the eight small European countries, as well as a guide for translating country BoD study results into health policy.
Identifiants
pubmed: 36271370
doi: 10.1186/s12961-022-00923-1
pii: 10.1186/s12961-022-00923-1
pmc: PMC9587663
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113Informations de copyright
© 2022. The Author(s).
Références
BMC Public Health. 2021 Oct 9;21(1):1827
pubmed: 34627228
Arch Public Health. 2020 Jan 9;78:3
pubmed: 31921418
AIDS. 2021 Mar 15;35(4):675-680
pubmed: 33259346
Minerva Cardiol Angiol. 2021 Jun;69(3):231-240
pubmed: 33703858
Int J Public Health. 2021 Mar 05;66:619011
pubmed: 34744580
Eur J Health Econ. 2021 Jun;22(4):505-518
pubmed: 33751289
Eur J Public Health. 2009 Oct;19(5):541-7
pubmed: 19401358
Int J Public Health. 2014 Jun;59(3):571-4
pubmed: 24748107
BMJ Open. 2021 Jun 16;11(6):e046117
pubmed: 34135042
Arch Public Health. 2020 Jul 23;78:68
pubmed: 32760586
Health Promot Pract. 2020 Jan;21(1):58-61
pubmed: 31841374
Health Res Policy Syst. 2018 Aug 17;16(1):82
pubmed: 30119676
Int J Public Health. 2020 Jul;65(6):719-720
pubmed: 32691080
Harm Reduct J. 2015 Feb 28;12:2
pubmed: 25884194
Eur J Public Health. 2020 Feb 1;30(1):2-3
pubmed: 31978226
Arch Public Health. 2021 May 11;79(1):73
pubmed: 33971960
BMC Med Res Methodol. 2019 Feb 4;19(1):27
pubmed: 30717671
CMAJ. 2009 Aug 4;181(3-4):165-8
pubmed: 19620273
Arch Public Health. 2021 Jul 29;79(1):138
pubmed: 34325736
J Contin Educ Health Prof. 2006 Winter;26(1):13-24
pubmed: 16557505
Biomed Res Int. 2018 Apr 23;2018:7236194
pubmed: 29850556
Lancet. 2013 Jul 6;382(9886):9-11
pubmed: 23684252